This episode is brought to you by TIKR. Join the free beta today at TIKR.com/hive. They're constantly releasing new updates that make the platform better including a new Business Owner Mode that hides share count, market cap and enterprise value. I couldn't be more excited to partner with TIKR.

Richard Chu is an investment analyst at Saga Partners where he seeks to find high-growth, highly asymmetric investment opportunities. How Richard ended up at Saga Partners is anything but traditional. Chu didn't have much investing experience after graduating college. Yet his passion for compounding wealth and knowledge boiled over into his first public investment write-up: Livongo (now, TDOC). 

Richard's first write-up caught the eyes of Joe Frankenfield at Saga Partners. This led to a conversation and eventual job for Chu at the firm. Now, Richard spends his time scouring the markets for new ideas. 

I loved this conversation as we covered a lot of ground. Our focus was on a few key topics: 

• GoHealth (GOCO)
• GoodRx (GDRX)
• Healthcare Investing
• UnHealthcare (Book)

Here's the time-stamp: 

• [0:00] Who is Richard Chu?
• [10:30] Why Healthcare?
• [13:40] The Journey to Zero to One in Finance
• [16:50] What is it like working for Saga Partners?
• [19:40] Go Health ($GOCO)
• [38:40] Go Health’s Competitors: Walmart
• [48:40] Go Health’s Valuation
• [1:02:00] Richard’s Next Ideas
• [1:13:50] A Day in The Life of Richard Chu
• [1:16:00] Closing Questions

If you'd like to learn more about Richard, check out these links: 

• Richard's Twitter
• Richard's Substack Newsletter